OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OncoTherapy Science Inc (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3493
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.

OncoTherapy Science Inc (4564) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Licensing Agreements 15
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
Equity Offering 16
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc – Key Competitors 17
OncoTherapy Science Inc – Key Employees 18
OncoTherapy Science Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 19
Recent Developments 20
Product News 20
Aug 08, 2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11
OncoTherapy Science and Theragen Etex to Form Joint Venture 12
OncoTherapy Science and Tella Enter into Co-Development Agreement 13
OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14
Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15
OncoTherapy Science Prices Private Placement Of Shares For US$12.7 Million 16
OncoTherapy Science Inc, Key Competitors 17
OncoTherapy Science Inc, Key Employees 18
OncoTherapy Science Inc, Subsidiaries 19
OncoTherapy Science Inc, Joint Venture 19

List of Figures
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[OncoTherapy Science Inc (4564):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marui Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Marui Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • TerniEnergia SpA (TER):企業のM&A・提携動向(発電分野)
    Summary TerniEnergia SpA (TerniEnergia), a subsidiary of Terni Research S.p.A., is an energy company that operates in the fields of renewable energy, energy efficiency, waste and energy management. The company operates in two sectors namely the environmental sector and the waste to energy (WTE) sect …
  • Patterson-UTI Energy, Inc.:企業の戦略・SWOT・財務分析
    SummaryPatterson-UTI Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Aprea AB-製薬・医療分野:企業M&A・提携分析
    Summary Aprea AB (Aprea) discovers and develops novel anticancer compounds targeting the tumor suppressor protein p53. The company’s lead drug candidate includes APR-246, an anti-cancer compound that targets and reactivates the tumor suppressor protein p53, inducing programmed cell death in many hum …
  • Wheelock and Company Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Wheelock and Company Limited Me …
  • PNC Wealth Management:企業の戦略・SWOT・財務情報
    PNC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary PNC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • VDM Group Limited (VMG):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "VDM Group Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows …
  • Taiwan Semiconductor Manufacturing Company Limited:企業のM&A・事業提携・投資動向
    Taiwan Semiconductor Manufacturing Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Taiwan Semiconductor Manufacturing Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business de …
  • Virgin Group Ltd.:企業のM&A・事業提携・投資動向
    Virgin Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Virgin Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Daiken Medical Co., Ltd. (7775):企業の財務及び戦略的SWOT分析
    Summary Daiken Medical Co., Ltd. (Daiken Medical) is a medical device company that provides anesthesia and infection control products. The company manufactures and distributes medical devices and equipments. It offers products such as syringe pump, portable disposable infusers, endobronchinal blocke …
  • Iljin Electric Co., Ltd. (103590):企業財務及び戦略的SWOT分析
    Summary Iljin Electric Co., Ltd. (Iljin Electric) a subsidiary of Iljin Holdings Co., Ltd. is a power company that offers electric equipment manufacturing services. The company offers generation, transmission and distribution services. It provides cable, materials, copper wire, electric materials, a …
  • Biogen, Inc.:製品開発パイプライン動向2015
    Biogen, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Biogen, Inc. - Product Pipeline Review - 2015’, provides an overview of the Biogen, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developm …
  • PT Bank Bukopin Tbk (BBKP):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "PT Bank Bukopin Tbk" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follo …
  • Maiden Holdings, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Maiden Holdings, Ltd. Mergers a …
  • Saudi Advanced Industries Company:企業概要及び財務分析
    Summary Strategic Defence Intelligence's "Saudi Advanced Industries Company - Company Profile and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financ …
  • Pirelli & C. S.p.A.:企業の戦略・SWOT・財務情報
    Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Pirelli & C. S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Travel24.com AG:企業の戦略・SWOT・財務分析
    SummaryTravel24.com AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …
  • Revalesio Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Revalesio Corp (Revalesio) is a developer of novel therapeutics for the treatment of inflammatory diseases. The company conducts research and development activities to develop therapeutics in the areas of respiratory, neuroscience and cardiovascular. Its product pipeline includes drugs targe …
  • Biolase Inc (BIOL):医療機器:M&Aディール及び事業提携情報
    Summary Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diod …
  • MedX Health Corp. (MDX):企業概要、財務及び戦略的SWOT分析
    Summary MedX Health Corp. (MedX) is a medical device company. The company designs, manufactures and distributes phototherapy devices. Its products include medx phototherapy, rehab laser console system, acupuncture laser console system, rehab portable laser, oralase (dental) portable laser, acupunctu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆